Abiomed Stock Price, News & Analysis

ABMD NASDAQ

Company Description

Abiomed (NASDAQ: ABMD) is a publicly traded surgical and medical instrument manufacturing company in the Manufacturing sector. The company has a market capitalization of $17.2B.

This page provides a comprehensive overview of ABMD stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.

Stock Performance

Chart

$—

0.00%

0.00

Last updated:

Performance 1 year

$17.2B

Market Cap

45.1M

Shares outstanding

Latest News

View All

December 21, 2022

+0.06%

FDA Approves Impella ECP Pivotal Heart Pump and First Patients Enrolled in Pivotal Clinical Trial

clinical trial fda approval

December 14, 2022

-0.05%

Johnson & Johnson Announces Extension of Abiomed Tender Offer to December 21, 2022

December 5, 2022

+0.27%

First Patients in the World Treated with Impella RP Flex with SmartAssist

November 1, 2022

+49.88%

Abiomed Announces Second Quarter Revenue of $266 Million, up 11% in Constant Currency*, up 7% on a Reported Basis Year Over Year

November 1, 2022

+49.88%

Johnson & Johnson to Acquire Abiomed

acquisition

October 31, 2022

-2.32%

Impella RP Flex with SmartAssist Receives FDA Approval to Treat Right Heart Failure

fda approval

Abiomed has 10 recent news articles. Of the recent coverage, 7 articles coincided with positive price movement and 3 with negative movement. Key topics include clinical trial, fda approval, acquisition, management. View all ABMD news →

SEC Filings

View All

No SEC filings available for ABMD.

Financial Highlights

View Full Financials

—

Revenue (TTM)

—

Net Income (TTM)

—

Diluted EPS (TTM)

—

Operating Cash Flow

—

Net Profit Margin

—

Oper. Profit Margin

Upcoming Events

Short Interest History

Last 12 Months

Days to Cover History

Last 12 Months

ABMD Company Profile & Sector Positioning

Abiomed (ABMD) operates in the Surgical and Medical Instrument Manufacturing industry within the broader Manufacturing sector and is listed on the NASDAQ.

Frequently Asked Questions

What is the market cap of Abiomed (ABMD)?

The market cap of Abiomed (ABMD) is approximately 17.2B. Learn more about what market capitalization means .